<VariationArchive RecordType="classified" VariationID="211771" VariationName="NM_000275.2(OCA2):c.647-?_807+?del" VariationType="Deletion" Accession="VCV000211771" Version="6" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-04-09" DateCreated="2015-10-05" MostRecentSubmission="2015-10-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="208146" VariationID="211771">
      <GeneList>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000275.2(OCA2):c.647-?_807+?del</Name>
      <VariantType>Deletion</VariantType>
      <Comment DataSource="ClinVar" Type="GenomicLocationNotEstablished">The genomic location for this variant will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis of the loss of exons from the cDNA.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000275.2(OCA2):c.647-?_807+?del AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV000194719" Version="6">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-04-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-04-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-05" MostRecentSubmission="2015-10-05">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="460007" SubmissionDate="2015-09-15" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_000275.2(OCA2):c.647-?_807+?del|Albinism, oculocutaneous, type II" />
        <ClinVarAccession Accession="SCV000248371" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-04-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000275.2:c.647-?_807+?del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Albinism, oculocutaneous, type II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="460007" TraitType="Disease" MappingType="Name" MappingValue="Albinism, oculocutaneous, type II" MappingRef="Preferred">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

